Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 4, 2000, Pages 1577-1583

  Majmudar, N G ^a   Robson, S C ^a   Ford, G A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CONJUGATED ESTROGEN; ESTROGEN; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITRIC OXIDE; NORADRENALIN; SEROTONIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; FOREARM BLOOD FLOW; GENDER; HUMAN; MALE; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0034457938     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.4.6530     Document Type: Article

References (44)

1. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
2. Menopause and the risk of coronary heart disease in women
3. Age at menopause as a risk factor for cardiovascular mortality
4. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
5. Raondomized trial of estrogen plus progestin for secondary proevention of coronary heart disease in postmenopausal women
6. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women
7. Ovarian sex steroids and atherosclerosis
8. High-density lipoprotein cholesterol, and cardiovascular disease: Four prospective American studies
9. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries
10. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease
11. 409 a new nitric-oxide donor suppresses smooth muscle proliferation in the rat model of balloon angioplasty
12. Estrogen improves endothelium-dependent, flow-mediated vasodilatation in post-menopausal women
13. Acute vascular effects of estrogen in postmenopausal women
14. The measurement of volume changes in human limbs
15. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis
16. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit
17. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol valerate and cyprotereone acetate or medroxyprogesterone acetate
18. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
19. Menopause is associated with endothelial dysfunction in women
20. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women
21. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women
22. Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor
23. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women
24. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors
25. G-monomethyl-L-arginine in men and women
26. Evidence for a difference In nitric oxide biosynthesis between healthy women and men
27. Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO
28. Gender difference in flow-induced dilation and regulation of shear stress: Role of estrogen and nitric oxide
29. + channels
30. Influence of gender on vascular reactivity in the rat
31. Ovariectomy eliminates sex differences in rat tail artery response to adrenergic nerve stimulation
32. The effects of male gender and female sex hormone deficiency on the vascular responses of the rat in vitro
33. 2- and β-adrenergic responses in human forearm
34. Estrogen increases endothelial nitric oxide by a receptor-mediated system
35. Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression
36. Flow-induced release of endothelium-derived relaxing factor
37. G-monomethyl-L-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal
38. Relative influence of menopausal status, age, and body mass index on blood pressure
39. Effect of hormone replacement therapy on lipoprtein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy
40. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients
41. Effects of long-term cigarette smoking on endothelium-dependent responses in humans
42. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus
43. Actions of oestrogen on vascular endothelial and smooth-muscle cells
44. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women